Search
for
Sort by
Research 61–90 of 1000+
- Pathophysiology of vitiligo
- Alopecia areata: An update
- Management of congenital ichthyoses: European guidelines of care, part two
- Vitiligo
- A wearable and stretchable dual-wavelength LED device for home care of chronic infected wounds
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Current management strategies for cutaneous T-cell lymphoma
- Topical and intralesional therapies for alopecia areata
- Recent advances in the treatment of psoriasis
- Harnessing the Power of Regenerative Therapy for Vitiligo and Alopecia Areata
- Off-Label Uses of Topical Vitamin D in Dermatology: A Systematic Review
- Guidelines for the Use of Acitretin in Psoriasis
- The treatment of alopecia areata.
- The treatment of alopecia areata
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Repigmentation of Poliosis After Epithelial Grafting for Vitiligo
- The Epidermal Vitamin D System and Innate Immunity: Some More Light Shed on This Unique Photoendocrine System?
- Vitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, U.K.
- Therapeutic and Diagnostic Applications of Nanotechnology in Dermatology and Cosmetics
- Laser therapy in superficial morphea lesions – indications, limitations and therapeutic alternatives
- Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
- Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial
- Body hair transplantation in vitiligo
- Mucin‐poor follicular mycosis fungoides
- CD8+ mycosis fungoides clinically masquerading as alopecia areata
- A Systematic Review of Outcomes and Patient Satisfaction Following Surgical and Non-surgical Treatments for Hair Loss
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- Understanding the Mechanism of Repigmentation in Vitiligo
- Immune therapies for alopecia areata: evidence and new perspectives
- Efficacy and safety of baricitinib in patients with refractory alopecia areata